{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T10:47:36Z","timestamp":1761130056398,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T00:00:00Z","timestamp":1677024000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Since the beginning, there has been enough evidence about the multi-systematic involvement of the coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Recent observations have revealed that, together with others, typical neurological manifestations are also associated with COVID-19 infection. In the first 2 years, children accounted for a few percent of cases, but with the emergence of the Omicron variant, the number of cases in the pediatric population has increased. It has been described that ~5% of the affected population suffered from severe neurological complications, such as seizure, coma, encephalitis, demyelinating disorders, and aseptic meningitis. Acute disseminated encephalomyelitis (ADEM) is an inflammatory demyelinating disease of the central nervous system. Typically, it presents in childhood and occurs 1 or 2 weeks after infection or vaccination.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>We present the case of a 12-year-old boy who developed ADEM, 10 days after an asymptomatic SARS-CoV-2 infection. Neurological symptoms began with headache, fever, irritability, paraplegia, and loss of sensitivity from the T1 level. The diagnosis of ADEM was confirmed by the typical signs found on brain MRI, whereas spinal cord MRI showed signs of transverse myelitis. The cerebrospinal fluid (CSF) testing excluded infections and did not reveal oligoclonal antibody bands (anti-MOG-negative and anti-AQP-negative). High-dose steroids (30 mg\/kg\/day) and IVIG (2 g\/kg) were administered to the patient without any clinical improvement. The patient received a cycle of plasma exchange therapy, followed by rituximab infusion, with partial improvement. After 3 months, the magnetic resonance imaging (MRI) results demonstrated radiological improvement in accordance with the ADEM diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This clinical case confirms that SARS-CoV-2 infections are increasingly implicated in severe neurological consequences in both adult and pediatric patients. While the most frequent complications that were reported in children included headache, altered mental status, and encephalopathy, ~5% of the individuals suffered from severe neurological complications, leading to lifelong sequelae. All physicians must be aware of these data and detect neurological signs of severe (or not) complications that require a specific follow-up and treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fneur.2023.1099458","type":"journal-article","created":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:51:36Z","timestamp":1677052296000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Case report: A case of acute disseminated encephalomyelitis after SARS-CoV-2 infection in pediatric patients"],"prefix":"10.3389","volume":"14","author":[{"given":"Francesca","family":"Cautilli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariavittoria","family":"Feleppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Papetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Monte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Midulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Spalice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,2,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/dmcn.15185","article-title":"Neurological effects of COVID-19 in infants and children","volume":"64","author":"Stafstrom","year":"2022","journal-title":"Dev Med Child Neurol."},{"key":"B2","unstructured":"UNICEF DATA ON LINE"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e20200702","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong","year":"2020","journal-title":"Pediatrics."},{"key":"B4","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1001\/jamaneurol.2021.0504","article-title":"Neurologic involvement in children and adolescents hospitalized in the United States for COVID-19 or multisystem inflammatory syndrome","volume":"78","author":"LaRovere","year":"2021","journal-title":"JAMA Neurol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S2352-4642(21)00193-0","article-title":"Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study","volume":"5","author":"Ray","year":"2021","journal-title":"Lancet Child Adolesc Health"},{"key":"B6","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1016\/j.autrev.2015.06.002","article-title":"A spectrum of inflammation and demyelination in acute disseminated encephalomyelitis (ADEM) of children","volume":"14","author":"Esposito","year":"2015","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2000","DOI":"10.1002\/acn3.51447","article-title":"Acute disseminated encephalomyelitis in a patient vaccinated against SARS-CoV-2","volume":"8","author":"Kania","year":"2021","journal-title":"Ann Clin Transl Neurol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"5570566","DOI":"10.1155\/2021\/5570566","article-title":"Rituximab treatment in acute disseminated encephalomyelitis associated with Salmonella infection","volume":"2021","author":"Kacmaz","year":"2021","journal-title":"Case Rep Pediatr."},{"key":"B9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s12519-022-00550-4","article-title":"COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner","volume":"18","author":"Valderas","year":"2022","journal-title":"World J Pediatr."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4694","DOI":"10.1007\/s12035-021-02450-6","article-title":"Emerging COVID-19 neurological manifestations: present outlook and potential neurological challenges in COVID-19 pandemic","volume":"58","author":"Dewanjee","year":"2021","journal-title":"Mol Neurobiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13052-021-01066-9","article-title":"Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature","volume":"47","author":"Siracusa","year":"2021","journal-title":"Ital J Pediatr."},{"key":"B12","doi-asserted-by":"publisher","first-page":"135567","DOI":"10.1016\/j.neulet.2020.135567","article-title":"Neurological issues in children with COVID-19","volume":"743","author":"Lin","year":"2021","journal-title":"Neurosci Lett."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1007\/s12031-020-01767-6","article-title":"Evidence of coronavirus (CoV) pathogenesis and emerging pathogen SARS-CoV-2 in the nervous system: a review on neurological impairments and manifestations","volume":"71","author":"Jha","year":"2021","journal-title":"J Mol Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.pediatrneurol.2021.12.010","article-title":"Prevalence and risk factors of neurologic manifestations in hospitalized children diagnosed with acute SARS-CoV-2 or MIS-C","volume":"128","author":"Fink","year":"2022","journal-title":"Pediatr Neurol."},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000999","article-title":"Systemic inflammation is associated with neurologic involvement in pediatric inflammatory multisystem syndrome associated with SARS-CoV-2","author":"Sa","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B16","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1212\/01.wnl.0000259404.51352.7f","article-title":"Acute disseminated encephalomyelitis","volume":"68","author":"Tenembaum","year":"2007","journal-title":"Neurology"},{"key":"B17","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1007\/s11910-003-0086-x","article-title":"Postinfectious encephalomyelitis","volume":"3","author":"Wingerchuk","year":"2003","journal-title":"Curr Neurol Neurosci Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult Scler"},{"key":"B19","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/ijms22010100","article-title":"Myelin oligodendrocyte glycoprotein antibody-associated disease: current insights into the disease pathophysiology, diagnosis and management","volume":"22","author":"Ambrosius","year":"2020","journal-title":"Int J Mol Sci."},{"key":"B20","doi-asserted-by":"publisher","first-page":"850743","DOI":"10.3389\/fnagi.2022.850743","article-title":"Clinical features and imaging findings of myelin oligodendrocyte glycoprotein-IgG-associated disorder (MOGAD)","volume":"14","author":"Li","year":"2022","journal-title":"Front Aging Neurosci."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2214\/AJR.20.24061","article-title":"MOGAD: how it differs from and resembles other neuroinflammatory disorders","volume":"216","author":"Shahriari","year":"2021","journal-title":"AJR Am J Roentgenol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e674","DOI":"10.1212\/NXI.0000000000000674","article-title":"International multicenter examination of MOG antibody assays","volume":"7","author":"Reindl","year":"2020","journal-title":"Neurol Neuroimmunol Neuroinflamm."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1111\/ene.15304","article-title":"Is there a correlation between MOG-associated disorder and SARS-CoV-2 infection?","volume":"29","author":"Mariotto","year":"2022","journal-title":"Eur J Neurol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"577933","DOI":"10.1016\/j.jneuroim.2022.577933","article-title":"Myelin oligodendrocyte glycoprotein-IgG associated disorders (MOGAD) following SARS-CoV-2 infection: a case series","volume":"370","author":"Lambe","year":"2022","journal-title":"J Neuroimmunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/acn3.51609","article-title":"SARS-CoV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder","volume":"9","author":"Johnsson","year":"2022","journal-title":"Ann Clin Transl Neurol."}],"container-title":["Frontiers in Neurology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1099458\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,22]],"date-time":"2023-02-22T07:51:39Z","timestamp":1677052299000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fneur.2023.1099458\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,22]]},"references-count":25,"alternative-id":["10.3389\/fneur.2023.1099458"],"URL":"https:\/\/doi.org\/10.3389\/fneur.2023.1099458","relation":{},"ISSN":["1664-2295"],"issn-type":[{"type":"electronic","value":"1664-2295"}],"subject":[],"published":{"date-parts":[[2023,2,22]]},"article-number":"1099458"}}